Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United States.

Curtis JR, Laster A, Becker DJ, Carbone L, Gary LC, Kilgore ML, Matthews RS, Morrisey MA, Saag KG, Tanner SB, Delzell E.

Osteoporos Int. 2009 Sep;20(9):1553-61. doi: 10.1007/s00198-008-0821-x. Epub 2008 Dec 24.

2.

Central DXA utilization shifts from office-based to hospital-based settings among medicare beneficiaries in the wake of reimbursement changes.

Zhang J, Delzell E, Zhao H, Laster AJ, Saag KG, Kilgore ML, Morrisey MA, Wright NC, Yun H, Curtis JR.

J Bone Miner Res. 2012 Apr;27(4):858-64. doi: 10.1002/jbmr.1534.

3.

Overuse of short-interval bone densitometry: assessing rates of low-value care.

Morden NE, Schpero WL, Zaha R, Sequist TD, Colla CH.

Osteoporos Int. 2014 Sep;25(9):2307-11. doi: 10.1007/s00198-014-2725-2. Epub 2014 May 9.

4.

Regional variation in the denial of reimbursement for bone mineral density testing among US Medicare beneficiaries.

Curtis JR, Laster AJ, Becker DJ, Carbone L, Gary LC, Kilgore ML, Matthews R, Morrisey MA, Saag KG, Tanner SB, Delzell E.

J Clin Densitom. 2008 Oct-Dec;11(4):568-74. doi: 10.1016/j.jocd.2008.07.004. Epub 2008 Sep 12.

5.

Osteoporosis care in the United States after declines in reimbursements for DXA.

Hayes BL, Curtis JR, Laster A, Saag K, Tanner SB, Liu C, Womack C, Johnson KC, Khaliq F, Carbone LD.

J Clin Densitom. 2010 Oct-Dec;13(4):352-60. doi: 10.1016/j.jocd.2010.08.001.

6.

DXA Utilization Between 2006 and 2012 in Commercially Insured Younger Postmenopausal Women.

Overman RA, Farley JF, Curtis JR, Zhang J, Gourlay ML, Deal CL.

J Clin Densitom. 2015 Apr-Jun;18(2):145-9. doi: 10.1016/j.jocd.2015.01.005. Epub 2015 Feb 18.

7.

Trends in dual-energy X-ray absorptiometry in the United States, 2000-2009.

O'Malley CD, Johnston SS, Lenhart G, Cherkowski G, Palmer L, Morgan SL.

J Clin Densitom. 2011 Apr-Jun;14(2):100-7. doi: 10.1016/j.jocd.2011.03.003.

PMID:
21787516
8.

Medicare payment cuts for osteoporosis testing reduced use despite tests' benefit in reducing fractures.

King AB, Fiorentino DM.

Health Aff (Millwood). 2011 Dec;30(12):2362-70. doi: 10.1377/hlthaff.2011.0233.

9.

Cost-effectiveness of fracture prevention in rural women with limited access to dual-energy X-ray absorptiometry.

Ito K, Leslie WD.

Osteoporos Int. 2015 Aug;26(8):2111-9. doi: 10.1007/s00198-015-3107-0. Epub 2015 Mar 26.

PMID:
25807913
10.

Does insufficient access to dual-energy X-ray absorptiometry (DXA) stifle the provision of quality osteoporosis care in New Zealand?

Milsom S, Leung W, Twigden V, Mitchell P, Nowitz M, Cornish J.

Arch Osteoporos. 2013;8:120. doi: 10.1007/s11657-013-0120-9. Epub 2013 Jan 30.

PMID:
23361437
11.

Osteoporosis care at risk in the United States.

Lewiecki EM, Baim S, Siris ES.

Osteoporos Int. 2008 Nov;19(11):1505-9. doi: 10.1007/s00198-008-0716-x. Epub 2008 Aug 29.

PMID:
18758881
12.

Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2006;6(20):1-180. Epub 2006 Nov 1.

13.

Effects of distance to care and rural or urban residence on receipt of radiation therapy among North Carolina Medicare enrollees with breast cancer.

Wheeler SB, Kuo TM, Durham D, Frizzelle B, Reeder-Hayes K, Meyer AM.

N C Med J. 2014 Jul-Aug;75(4):239-46.

14.

Longitudinal trends in use of bone mass measurement among older americans, 1999-2005.

Curtis JR, Carbone L, Cheng H, Hayes B, Laster A, Matthews R, Saag KG, Sepanski R, Tanner SB, Delzell E.

J Bone Miner Res. 2008 Jul;23(7):1061-7. doi: 10.1359/jbmr.080232.

15.

Examining the impact of reimbursement on referral to bone density testing for older adults: 8 years of data from the Barwon Statistical Division, Australia.

Brennan SL, Kotowicz MA, Sarah B, Leslie WD, Ebeling PR, Metge CJ, Dobbins AG, Pasco JA.

Arch Osteoporos. 2013;8:152. doi: 10.1007/s11657-013-0152-1. Epub 2013 Sep 27.

PMID:
24072727
16.

Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy.

Shea AM, Curtis LH, Hammill BG, DiMartino LD, Abernethy AP, Schulman KA.

JAMA. 2008 Jul 9;300(2):189-96. doi: 10.1001/jama.300.2.189.

PMID:
18612116
17.

A population-based study of osteoporosis testing and treatment following introduction of a new bone densitometry service.

Leslie WD, MacWilliam L, Lix L, Caetano P, Finlayson GS.

Osteoporos Int. 2005 Jul;16(7):773-82. Epub 2004 Oct 2. Erratum in: Osteoporos Int. 2006 Jul;17(7):1119.

PMID:
15580480
18.

Low rates of bone mineral density measurement in Medicare beneficiaries with prostate cancer initiating androgen deprivation therapy.

Suarez-Almazor ME, Peddi P, Luo R, Nguyen HT, Elting LS.

Support Care Cancer. 2014 Feb;22(2):537-44. doi: 10.1007/s00520-013-2008-z. Epub 2013 Oct 22.

19.

Breast cancer stage at diagnosis and geographic access to mammography screening (New Hampshire, 1998-2004).

Celaya MO, Berke EM, Onega TL, Gui J, Riddle BL, Cherala SS, Rees JR.

Rural Remote Health. 2010 Apr-Jun;10(2):1361. Epub 2010 Apr 23.

20.

Access to osteoporosis treatment is critically linked to access to dual-energy x-ray absorptiometry testing.

Cadarette SM, Gignac MA, Jaglal SB, Beaton DE, Hawker GA.

Med Care. 2007 Sep;45(9):896-901.

PMID:
17712261

Supplemental Content

Support Center